Introduction Semaglutide has revolutionized the treatment of type 2 diabetes and obesity, offering a unique combination of benefits for weight management, blood sugar control, and cardiovascular protection. As a GLP-1 receptor agonist, it mimics the natural hormone glucagon-like peptide-1, which regulates critical processes such as appetite, insulin secretion, and glucose https://brookssvybc.wikipresses.com/4827694/semaglutide_a_breakthrough_in_managing_diabetes_weight_and_heart_health